Apyx Medical Corporation (APYX)
USD 1.58
(-3.66%)
USD 1.58
(-3.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.24 Million | -20.28 Million | -10.44 Million | -16.06 Million | -18.47 Million | -21.01 Million |
| Net Income | -18.71 Million | -23.27 Million | -15.2 Million | -11.9 Million | -19.7 Million | 64 Million |
| Depreciation & Amortization | 692 Thousand | 890 Thousand | 903 Thousand | 887 Thousand | 754 Thousand | 669 Thousand |
| Deferred income taxes | -10.04 Million | - | - | - | - | -368 Thousand |
| Stock-based compensation | 5.11 Million | 6.69 Million | 5.08 Million | 4.21 Million | 3.58 Million | 1.52 Million |
| Change in working capital | 5.54 Million | -5.21 Million | -1.84 Million | -10.25 Million | -3.31 Million | -18.39 Million |
| Other non-cash items | 12.16 Million | 628 Thousand | 603 Thousand | 996 Thousand | 215 Thousand | -68.44 Million |
| Investing Cash Flow | 6.88 Million | -1.01 Million | -723 Thousand | -581 Thousand | 60.54 Million | 29.3 Million |
| Investments in PPE | -533 Thousand | -1.01 Million | -723 Thousand | -581 Thousand | -1.3 Million | -363 Thousand |
| Acquisitions | 7.41 Million | - | 195 Thousand | - | -80.72 Million | 91.09 Million |
| Investment purchases | - | - | - | - | -18.88 Million | -87.18 Million |
| Sales/Maturities of investments | - | - | - | - | 80.72 Million | 25.75 Million |
| Other Investing Activities | 7.26 Million | - | -195 Thousand | - | 80.72 Million | 29.66 Million |
| Financing Cash Flow | 32.01 Million | 217 Thousand | 24 Thousand | -73 Thousand | 147 Thousand | -2.49 Million |
| Debt repayment | -29.3 Million | -148 Thousand | -238 Thousand | -369 Thousand | -60 Thousand | -2.69 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.71 Million | 365 Thousand | 67 Thousand | 148 Thousand | 207 Thousand | 202 Thousand |
| Other Financing Activities | 58.6 Million | 217 Thousand | 195 Thousand | 148 Thousand | 147 Thousand | 202 Thousand |
| Accounts receivables | -3.57 Million | 1.91 Million | -4.9 Million | -558 Thousand | -3.97 Million | -382 Thousand |
| Accounts payables | 25 Thousand | 67 Thousand | 1.15 Million | -965 Thousand | 1.05 Million | -224 Thousand |
| Inventory | 1.45 Million | -5.56 Million | -2.85 Million | 615 Thousand | -2.36 Million | -881 Thousand |
| Other working capital | 7.63 Million | -1.63 Million | 4.76 Million | -9.34 Million | 1.96 Million | -16.91 Million |
| Cash at beginning of period | 10.19 Million | 30.87 Million | 41.91 Million | 58.81 Million | 16.59 Million | 10.66 Million |
| Cash at end of period | 43.65 Million | 10.19 Million | 30.87 Million | 41.91 Million | 58.81 Million | 16.46 Million |
| Capital Expenditure | -533 Thousand | -1.01 Million | -723 Thousand | -581 Thousand | -1.3 Million | -363 Thousand |
| Effect of forex changes on cash | -191 Thousand | 395 Thousand | 103 Thousand | -177 Thousand | 3000.00 | - |
| Net cash flow / Change in cash | 33.46 Million | -20.67 Million | -11.04 Million | -16.89 Million | 42.21 Million | 5.79 Million |
| Free Cash Flow | -5.78 Million | -21.29 Million | -11.17 Million | -16.64 Million | -19.77 Million | -21.37 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.55 Million | -7.57 Million | -9.6 Million | -18.71 Million | -4.67 Million | -1.01 Million |
| Depreciation & Amortization | 156 Thousand | 157 Thousand | 152 Thousand | 692 Thousand | 186 Thousand | 151 Thousand |
| Deferred income taxes | - | - | -1.96 Million | -10.04 Million | 208 Thousand | -2.31 Million |
| Stock-based compensation | 1.05 Million | 1.12 Million | 914 Thousand | 5.11 Million | 1.35 Million | 1.48 Million |
| Change in working capital | 700 Thousand | -315 Thousand | 2.25 Million | 5.54 Million | 6.44 Million | -3.31 Million |
| Other non-cash items | 1.72 Million | 828 Thousand | 7.79 Million | 12.16 Million | 179 Thousand | 164 Thousand |
| Investing Cash Flow | -289 Thousand | -35 Thousand | -93 Thousand | 6.88 Million | -174 Thousand | 7.11 Million |
| Investments in PPE | -289 Thousand | -35 Thousand | -93 Thousand | -533 Thousand | -174 Thousand | -156 Thousand |
| Acquisitions | - | - | -7.41 Million | 7.41 Million | 147 Thousand | 7.26 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 7.41 Million | 7.26 Million | -147 Thousand | 7.26 Million |
| Financing Cash Flow | -5000.00 | -5000.00 | 22.09 Million | 32.01 Million | 164 Thousand | 46 Thousand |
| Debt repayment | -5000.00 | -5000.00 | -20.04 Million | -29.3 Million | -13 Thousand | -10 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 2.04 Million | 2.71 Million | 30 Thousand | 56 Thousand |
| Other Financing Activities | - | - | 40.08 Million | 58.6 Million | 147 Thousand | 46 Thousand |
| Accounts receivables | -291 Thousand | 1.47 Million | -1.38 Million | -3.57 Million | -751 Thousand | -2.27 Million |
| Accounts payables | 254 Thousand | -599 Thousand | 638 Thousand | 25 Thousand | -587 Thousand | 750 Thousand |
| Inventory | 409 Thousand | 138 Thousand | 1.05 Million | 1.45 Million | -133 Thousand | -345 Thousand |
| Other working capital | 737 Thousand | -1.19 Million | 1.93 Million | 7.63 Million | 7.91 Million | -1.44 Million |
| Cash at beginning of period | 37.28 Million | 43.65 Million | 22.13 Million | 10.19 Million | 18.47 Million | 16.25 Million |
| Cash at end of period | 32.67 Million | 37.28 Million | 43.65 Million | 43.65 Million | 22.13 Million | 18.47 Million |
| Capital Expenditure | -289 Thousand | -35 Thousand | -93 Thousand | -533 Thousand | -174 Thousand | -156 Thousand |
| Effect of forex changes on cash | 19 Thousand | 11 Thousand | -21 Thousand | -191 Thousand | -31 Thousand | -81 Thousand |
| Net cash flow / Change in cash | -4.6 Million | -6.37 Million | 21.51 Million | 33.46 Million | 3.65 Million | 2.22 Million |
| Free Cash Flow | -4.61 Million | -6.37 Million | -551 Thousand | -5.78 Million | 3.52 Million | -5 Million |
300860
AIAGY
AERI3
002829
300017
002948